부산대학교 도서관

Perrier, L ; Tredan, O ; Morelle, M ; Penel, N ; Fournel, P ; Greillier, L ; Ghiringhelli, F ; Tosi, D ; Bertucci, F ; Campone, M ; Delord, JP ; Pouessel, D ; Garin, G ; Chabaud, S ; Gomez-Roca, C ; Pannier, D ; Brahmi, M ; Fabbro, M ; Garcia, ME ; Ray-Coquard, I ; Viala, M ; Italiano, A ; Cassier, P ; Dufresne, A ; Attignon, V ; Treilleux, I ; Viari, A ; de la Motte Rouge, T ; Durando, X ; Perol, D ; Blay, JY

In Value in Health December 2022 25(12) Supplement:S175-S175

Filippini DM; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France; Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum, Università di Bologna, Bologna, Italy.; Cabarrou B; University of Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Biostatistics & Health Data Science Unit, Toulouse, France.; Dupain C; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France.; Halladjian M; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France.; Coquan E; Department of Medical Oncology, Centre Francois Baclesse, Caen, Cedex, France.; Sablin MP; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France.; Mazzarella L; Laboratory of Translational Oncology, European Institute of Oncology IRCCS, Milan, Italy.; Francisco M; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France.; Servant N; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France.; Tonini MM; Translational Medicine Operations Hub, Luxembourg Institute of Health, Luxembourg.; Hundt AF; Translational Medicine Operations Hub, Luxembourg Institute of Health, Luxembourg.; Castel-Ajgal Z; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France.; You B; Department of Medical Oncology, Hospices de Lyon, Lyon, France.; Bigot F; Institut de Cancérologie de l'Ouest, Angers, France.; Ghiringhelli F; Centre Georges-François Leclerc, Dijon, France.; Vansteene D; Institut de Cancérologie de l'Ouest, Saint-Herblain, France.; Gomez-Roca C; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.; Cousin S; Institut Bergonié, Bordeaux, France.; Lambert A; Institut de Cancérologie de Lorraine, Vandœuvre-Lès-Nancy, France.; Saada-Bouzid E; Centre Antoine Lacassagne, Nice, France.; Durando X; Centre Jean Perrin, Clermont-Ferrand, France.; Abdeddaim C; Centre Oscar Lambert, Lille, France.; Borel C; Department of Medical Oncology, ICANS, Strasbourg, France.; Chaltiel R; Department of Medical Oncology, Institut Jean Godinot, Reims, France.; Borcoman E; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France.; Legrand F; R&D Department, Unicancer, Paris, France.; Bernhart S; IZBI, Interdisciplinary Centre for Bioinformatics, Universität Leipzig, Leipzig, Germany.; Jimenez M; R&D Department, Unicancer, Paris, France.; Bièche I; Department of Genetics, Institut Curie, Paris, France.; Filleron T; University of Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Biostatistics & Health Data Science Unit, Toulouse, France.; Le Tourneau C; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France; Paris-Saclay University, Paris, France.; Kamal M; Department of Drug Development and Innovation (D3I), Institut Curie, Paris, France.; Jeannot E; Department of Genetics, Institut Curie, Paris, France; Department of Pathology, Institut Curie, Paris, France. Electronic address: emmanuelle.jeannot@curie.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Korakis I; Department of Medical Oncology, Clinical Research Unit, Oncopole Claudius Regaud-IUCT-O, Toulouse, France. Electronic address: korakis.iphigenie@iuct-oncopole.fr.; Ouali K; Drug Development Department, Gustave Roussy Cancer Center, Villejuif, France.; Hanvic B; Department of Medical Oncology, France.; Verlingue L; Department of Medical Oncology, France.; Allignet B; Department of Radiation Oncology, Centre Léon Bérard, Lyon, France; Department of Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, CNRS, Inserm, CREATIS UMR 5220, U1294 Lyon, France.; Lusque A; Department of Biostatistics & Health Data Science Unit, Oncopole Claudius Regaud-IUCT-O, Toulouse, France.; Clementei S; Department of Medical Oncology, Clinical Research Unit, Oncopole Claudius Regaud-IUCT-O, Toulouse, France.; Magne E; Department of Medical Oncology, Clinical Research Unit, Oncopole Claudius Regaud-IUCT-O, Toulouse, France.; Massard C; Drug Development Department, Gustave Roussy Cancer Center, Villejuif, France.; Delord JP; Department of Medical Oncology, Clinical Research Unit, Oncopole Claudius Regaud-IUCT-O, Toulouse, France.; Cassier P; Department of Medical Oncology, France.; Baldini C; Drug Development Department, Gustave Roussy Cancer Center, Villejuif, France.; Segier B; Department of Biostatistics & Health Data Science Unit, Oncopole Claudius Regaud-IUCT-O, Toulouse, France.; Gomez-Roca C; Department of Medical Oncology, Clinical Research Unit, Oncopole Claudius Regaud-IUCT-O, Toulouse, France.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Cherny NI; Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. Electronic address: mcbs@esmo.org.; Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Dafni U; Laboratory of Biostatistics, Division of Public Health, Department of Nursing, University of Athens, Athens; Frontier Science Foundation-Hellas, Athens, Greece.; Latino NJ; ESMO Head Office, European Society for Medical Oncology, Lugano, Switzerland.; Galotti M; ESMO Head Office, European Society for Medical Oncology, Lugano, Switzerland.; Zygoura P; Frontier Science Foundation-Hellas, Athens, Greece; Athens University of Economics and Business, Athens, Greece.; Dimopoulou G; Frontier Science Foundation-Hellas, Athens, Greece.; Amaral T; Skin Cancer Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.; Barriuso J; The Christie NHS Foundation Trust and Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Calles A; Medical Oncology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain.; Kiesewetter B; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Gomez-Roca C; Institut Universitaire du Cancer de Toulouse (IUCT)-Oncopole, Institut Claudius Regaud, Toulouse, France.; Gyawali B; Department of Oncology, Queen's University, Kingston, Canada.; Piccart M; Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium.; Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy.; Roitberg F; Rede Ebserh (Empresa Brasileira de Serviços Hospitalares), Brasilia, Brazil.; Tarazona N; Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.; Trapani D; European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Curigliano G; European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Wester R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Zarkavelis G; University of Ioannina, Department of Medical Oncology, Ioannina, Greece.; Zielinski C; Wiener Privat Klinik, Central European Academy Cancer Center, Vienna, Austria.; de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Ott, PA; Piha-Paul, SA; Munster, P; Pishvaian, MJ; van Brummelen, EMJ; Cohen, RB; Gomez-Roca, C; Ejadi, S; Stein, M; Chan, E; Simonelli, M; Morosky, A; Saraf, S; Emancipator, K; Koshiji, M; Bennouna, J

Ann Oncol
Annals of Oncology, vol 28, iss 5

Blay JY; Department of Medicine, CentreLeon bErard, Lyon. Electronic address: jean-yves.blay@lyon.unicancer.fr.; Cropet C; DRCI, Centre Leon Berard, Lyon.; Mansard S; Dermatology Department, Hôpital Estaing, University Hospital of Clermont Ferrand, Clermont-Ferrand.; Loriot Y; Department of Medicine, Gustave Roussy, Villejuif.; De La Fouchardière C; DRCI, Centre Leon Berard, Lyon.; Haroche J; Department of Internal Medicine, Institut E3M, French Reference Centre for Histiocytosis, Pitié-Salpȇtrière, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris.; Topart D; Onco-urology Department, Hôpital Saint ELOI, Montpellier.; Tougeron D; Gastroenterology and Hepatology Department, Poitiers University Hospital and Faculty of Medicine of Poitiers, Poitiers.; You B; Centre d'Investigation des Thérapeutiques en Oncologie et Hématologie de Lyon (CITOHL), Hospices Civils de Lyon (IC-HCL), EA 3738 CICLY, Lyon.; Italiano A; Department of Medicine, Institut Bergonié, Bordeaux; Faculty of Medicine, University of Bordeaux, Bordeaux.; Le Brun-Ly V; Department of Medicine, CHU Limoges, Medical Oncology, Limoges.; Ferrero JM; Department of Medicine, Centre A. Lacassagne, Nice.; Penel N; Department of Medical Oncology, Centre Oscar Lambret, Lille; Université de Lille, CHU Lille, ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, Lille.; Fabbro M; Department of Medicine, Institut de Cancerologie de Montpellier, Montpellier.; Troussard X; Department of Oncology, CHU Caen, Caen.; Malka D; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris.; Ray-Coquard I; Department of Medicine, CentreLeon bErard, Lyon.; Leboulleux S; Department of Medicine, Gustave Roussy, Villejuif.; Fléchon A; DRCI, Centre Leon Berard, Lyon.; Maubec E; Assistance Publique-Hôpitaux de Paris, Department of Dermatology, Hôpital Avicenne, Bobigny; University Sorbonne Paris Nord - Campus de Bobigny, Bobigny and UMR 1124, Campus Saint-Germain-des-Prés, Paris.; Charles J; Dermatology, Allergology & Photobiology Department, CHU Grenoble Alpes, Grenoble; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR5309, Université Grenoble Alpes, La Tronche.; Dalle S; Department of Dermatology, Hospices Civils de Lyon, CRCL, Université Claude Bernard Lyon1, Lyon.; Taieb S; Department of Medical Oncology, Centre Oscar Lambret, Lille.; Garcia GCTE; Department of Medicine, Gustave Roussy, Villejuif.; Mandache AM; DRCI, Centre Leon Berard, Lyon.; Colignon N; Department of Radiology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris.; Gavrel M; Department of Medicine, Gustave Roussy, Villejuif.; Nowak F; Institut National Du Cancer, Boulogne-Billancourt.; Hoog Labouret N; Institut National Du Cancer, Boulogne-Billancourt.; Mahier Aït Oukhatar C; Department Unicancer R&D, Unicancer, Paris.; Gomez-Roca C; Institut Claudius Regaud/Institut Universitaire du Cancer de Toulouse (IUCT-Oncopole), Clinical Research Unit, Toulouse, France.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Berthon, C; Raffoux, E; Thomas, X; Vey, N; Gomez-Roca, C; Yee, K; Taussig, DC; Rezai, K; Roumier, C; Herait, P; Kahatt, C; Quesnel, B; Michallet, M; Recher, C; Lokiec, F; Preudhomme, C; Dombret, H

The Lancet Haematology. 3:e186-e195

Sibaud V; Departments of Oncodermatology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.; Eid C; Dermatology Service, Centre Intégré de Santé et des Services Sociaux de Laval, Université de Montréal, Montréal, Qc, Canada.; Belum VR; Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Combemale P; Oncodermatology Service - Centre Leon Berard, Lyon, France.; Barres B; Departments of Pathology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.; Lamant L; Departments of Pathology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.; Mourey L; Departments of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.; Gomez-Roca C; Departments of Medical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.; Estilo CL; Dental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Motzer R; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Vigarios E; Departments of Oral Medicine, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.; Lacouture ME; Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE

Gyawali B; Department of Oncology, Queen's University, Kingston, Ontario, Canada; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada; Division of Cancer Care and Epidemiology, Queen's University, Kingston, Ontario, Canada. Electronic address: gyawali.bishal@queensu.ca.; de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Dafni U; Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens, Athens; Frontier Science Foundation-Hellas, Athens, Greece.; Amaral T; Skin Cancer Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.; Barriuso J; The Christie NHS Foundation Trust and Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Bogaerts J; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.; Calles A; Medical Oncology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain.; Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan; European Institute of Oncology, IRCCS, Milan, Italy.; Gomez-Roca C; Institut Universitaire du Cancer de Toulouse (IUCT), Toulouse, France.; Kiesewetter B; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.; Oosting S; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Passaro A; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy.; Pentheroudakis G; ESMO Head Office, Lugano, Switzerland.; Piccart M; Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.; Roitberg F; WHO Cancer Management Consultant, Geneva, Switzerland; Instituto do Cancer do Estado de São Paulo (ICESP HCFMUSP), São Paulo, Brazil.; Tabernero J; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), UVic-UCC, IO-Quiron, Barcelona, Spain.; Tarazona N; Department of Medical Oncology, Biomedical Research Institute INCLIVA, CIBERONC, University of Valencia, Valencia, Spain.; Trapani D; European Institute of Oncology, IRCCS, Milan, Italy.; Wester R; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Zarkavelis G; University of Ioannina-Department of Medical Oncology, Ioannina, Greece.; Zielinski C; Central European Cooperative Oncology Group and Central European Cancer Center, Wiener Privatklinik, Vienna, Austria.; Zygoura P; Frontier Science Foundation-Hellas, Athens, Greece.; Cherny NI; Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.

Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Vigarios E; Oral Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.; UFR Odontologie, 3 Chemin des Maraîchers, 31062, Toulouse CEDEX 9, France.; Lamant L; Pathology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.; Delord JP; Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.; Fricain JC; Oral Medicine Department, Pôle Odontologie et Santé Buccale, Hôpital Pellegrin, Place Amélie-Raba-Léon, 33076, Bordeaux CEDEX, France.; UFR Odontologie Bordeaux, 16-20 Cours de la Marne, 33076, Bordeaux CEDEX, France.; Chevreau C; Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.; Barrés B; Pathology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.; Gomez-Roca C; Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.; Boulanger M; Oral Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.; UFR Odontologie, 3 Chemin des Maraîchers, 31062, Toulouse CEDEX 9, France.; Sibaud V; Dermatology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

Hollebecque A; Deutsch E; Massard C; Gomez-Roca C; Bahleda R; Ribrag V; Bourgier C; Lazar V; Lacroix L; Gazzah A; Varga A; de Baere T; Beier F; Kroesser S; Trang K; Zenke FT; Klevesath M; Soria JC

Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Modesto A; Département de radiothérapie, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France. Electronic address: modesto.anouchka@iuct-oncopole.fr.; Chira C; Département de radiothérapie, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.; Sol JC; Département de neurochirurgie, hôpital Purpan, CHU de Toulouse, 1, place Dr-Baylac, 31000 Toulouse, France; Unité Gamma Knife, hôpital Purpan, CHU de Toulouse, 1, place Dr-Baylac, 31000 Toulouse, France.; Lubrano V; Département de neurochirurgie, hôpital Purpan, CHU de Toulouse, 1, place Dr-Baylac, 31000 Toulouse, France; Unité Gamma Knife, hôpital Purpan, CHU de Toulouse, 1, place Dr-Baylac, 31000 Toulouse, France.; Boulinguez S; Département d'oncologie médicale, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.; Pagès C; Département d'oncologie médicale, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.; Sibaud V; Département d'oncologie médicale, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.; Gomez-Roca C; Département d'oncodermatologie, institut universitaire du cancer de Toulouse-Oncopole, CHU de Toulouse, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.; Moyal É; Département de radiothérapie, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France; Unité Gamma Knife, hôpital Purpan, CHU de Toulouse, 1, place Dr-Baylac, 31000 Toulouse, France.; Meyer N; Département d'oncologie médicale, institut Claudius-Regaud, institut universitaire du cancer de Toulouse-Oncopole, 1, avenue Irène-Joliot-Curie, 31059 Toulouse cedex 9, France.

Publisher: Elsevier Country of Publication: France NLM ID: 9711272 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6658 (Electronic) Linking ISSN: 12783218 NLM ISO Abbreviation: Cancer Radiother Subsets: MEDLINE

Hollebecque A; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France. Electronic address: Antoine.HOLLEBECQUE@gustaveroussy.fr.; Bahleda R; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Faivre L; Gustave Roussy, Université Paris-Saclay, Service de biostatistique et d'épidémiologie, Villejuif, F-94805, France.; Adam J; Gustave Roussy, Université Paris-Saclay, Département de biologie et pathologie médicales, Villejuif, F-94805, France.; Poinsignon V; Gustave Roussy, Université Paris-Saclay, Pharmacology and Drug analysis department, Villejuif, F-94805, France.; Paci A; Gustave Roussy, Université Paris-Saclay, Pharmacology and Drug analysis department, Villejuif, F-94805, France.; Gomez-Roca C; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Thery JC; University Hospital Pitié Salpêtrière, Department of Medical Oncology, University Pierre and Marie Curie, Paris, France.; Le Deley MC; Gustave Roussy, Université Paris-Saclay, Service de biostatistique et d'épidémiologie, Villejuif, F-94805, France.; Varga A; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Gazzah A; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Ileana E; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Gharib M; University Hospital Pitié Salpêtrière, Department of Medical Oncology, University Pierre and Marie Curie, Paris, France.; Angevin E; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Malekzadeh K; Gustave Roussy, Université Paris-Saclay, Service de biostatistique et d'épidémiologie, Villejuif, F-94805, France.; Massard C; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Soria JC; Gustave Roussy, Université Paris-Saclay, Drug Development Department, Villejuif, F-94805, France.; Spano JP; University Hospital Pitié Salpêtrière, Department of Medical Oncology, University Pierre and Marie Curie, Paris, France.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Isambert N; Department of Medical Oncology, Centre Georges François Leclerc, Dijon.; Delord JP; Oncology and Clinical Research Unit, Institut Claudius Regaud, Toulouse.; Soria JC; Drug Development Department (DITEP), Gustave Roussy Cancer Campus and University Paris-Sud, Paris, France.; Hollebecque A; Drug Development Department (DITEP), Gustave Roussy Cancer Campus and University Paris-Sud, Paris, France.; Gomez-Roca C; Oncology and Clinical Research Unit, Institut Claudius Regaud, Toulouse.; Purcea D; Debiopharm International SA, Lausanne, Switzerland.; Rouits E; Debiopharm International SA, Lausanne, Switzerland.; Belli R; Debiopharm International SA, Lausanne, Switzerland.; Fumoleau P; Department of Medical Oncology, Centre Georges François Leclerc, Dijon. Electronic address: pfumoleau@cgfl.fr.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Cassier PA; Drug Development Unit, The Royal Marsden National Health Service Foundation Trust, Sutton The Institute of Cancer Research, Sutton, UK Departments of Medical Oncology cassierp@hotmail.com.; Polivka V; Biostatistics, Centre Léon Bérard, Lyon.; Judson I; Drug Development Unit, The Royal Marsden National Health Service Foundation Trust, Sutton The Institute of Cancer Research, Sutton, UK.; Soria JC; Department of Medicine, Institut Gustave Roussy, Villejuif.; Penel N; Department of General Cancer, Centre Oscar Lambret, Lille, France.; Marsoni S; Southern Europe New Drug Organization Foundation, Milan, Italy.; Verweij J; Erasmus University Medical Center, Cancer Institute, Rotterdam.; Schellens JH; The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Morales-Barrera R; Research Unit for Molecular Therapy of Cancer, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.; Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium.; Voest EE; University Medical Center Utrecht, Utrecht, The Netherlands.; Gomez-Roca C; Department of Medicine, Institut Gustave Roussy, Villejuif.; Evans TR; The Beatson West of UK Cancer Centre, Glasgow.; Plummer R; Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK.; Gallerani E; Department of Oncology, Istituto Oncologico Della Svizzera Italiana, Bellinzona, Switzerland.; Kaye SB; Drug Development Unit, The Royal Marsden National Health Service Foundation Trust, Sutton The Institute of Cancer Research, Sutton, UK.; Olmos D; Drug Development Unit, The Royal Marsden National Health Service Foundation Trust, Sutton The Institute of Cancer Research, Sutton, UK.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE